-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Review Article: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Design, findings and implications of the liraglutide Phase III clinical trial program
Bruce W Bode
Review: Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation